Effect of low dose weekly methotrexate on bone mineral density and bone turnover [4]

Annals of the Rheumatic Diseases

Volumn 62, Issue 2, 2003, Pages 186-187

  Patel, S ^a   Patel, G ^b   Johnson, D ^b   Ogunremi, L ^b   Barron, J ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; DISEASE DURATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; INTERVIEW; LETTER; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; STRESS FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE REMODELING; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS;

EID: 0037310880     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.2.186     Document Type: Letter

References (5)

1. Wijnands M, Burgers A. Stress fracture in long term methotrexate treatment for psoriaritic arthritis. Ann Rheum Dis 2001;60:736-8.
2. Mazzantini M, Di Munno O. Methotrexate and bone mass. Clin Exp Rheumatol 2000;18:S87-92.
3. Gluer CC, Blake G, Blunt BA, Jergas M, Genant K. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 1995;5:262-70.
4. Lems WF, Dijkmans BAC. Should we look for osteoporosis in patients with rheumatoid arthritis?Ann Rheum Dis 1998;57:325-7.
5. Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001;26:446-8.